# FDA recall D-0875-2017

> **SCA Pharmaceuticals** · Class II · drug recall initiated 2017-05-18.

## Product

HYDROmorphone HCL in 0.9% Sodium Chloride injectable, 0.2 mg per ml, Total Volume 100mL, Single Dose Container bag, (Total HYDROmorphone Dose 20 mg per 100 mL) Preservative Free, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205, NDC 70004-0300-55

## Reason for recall

Lack of assurance of sterility: Product bags leaking at seam.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0875-2017
- **Recalling firm:** SCA Pharmaceuticals
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-05-18
- **Report date:** 2017-06-07
- **Termination date:** 2018-03-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Little Rock, AR, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0875-2017

## Citation

> AI Analytics. FDA recall D-0875-2017. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/D-0875-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*
